CBLC and hyperinsulinemic hypoglycemia, familial, 4: Methionine, which was top ranked by MDA analysis for MMA, has been associated with differences in MMA phenotypic subgroups, with lower levels in patients with remethylation defects (CblC, D or F) compared to mutase deficiency (mut0/−) [15,30].